Abstract
Abstract
Background
Gene selection from gene expression profiles is the appropriate tool for diagnosing and predicting cancers. The aim of this study is to perform a Precision Lasso regression model on gene expression of diffuse large B cell lymphoma patients and to find marker genes related to DLBCL.
Methods
In the present case–control study, the dataset included 180 gene expressions from 14 healthy individuals and 17 DLBCL patients. The marker genes were selected by fitting Ridge, Lasso, Elastic Net, and Precision Lasso regression models.
Results
Based on our findings, the Precision Lasso, the Ridge, the Elastic Net, and the Lasso models choose the most marker genes, respectively. In addition, the top 20 genes are based on models compared with the results of clinical studies. The Precision Lasso and the Ridge models selected the most common genes with the clinical results, respectively.
Conclusions
The performance of the Precision Lasso model in selecting related genes could be considered more acceptable rather than other models.
Funder
Arak University of Medical Sciences
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Wood NK, Goaz PW. Differential diagnosis of oral and maxillofacial lesions, 90. Mosby; 5th edition St. Louis: Don ladig; 1997.
2. Fouladseresht H, et al. The incidence of non-Hodgkin lymphoma in Iran: a systematic review and meta-analysis. World Cance Res J. 2019;6:e1261.
3. Shi Y, et al. Reproducibility of quantitative real-time PCR analysis in microRNA expression profiling and comparisons with microarray assays in diffuse large B-cell lymphoma patients. Int J Clin Exp Med. 2019;12(5):5776–84.
4. Sehn LH, Gascoyne RD. Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity. J Am Soc Hematol. 2015;125(1):22–32.
5. Zhuang H, et al. MicroRNA-146a rs2910164 polymorphism and the risk of diffuse large B cell lymphoma in the Chinese Han population. Med Oncol. 2014;31:306.